Key result
Lowering pH to 4.6 quenched the conformational exchange of the FUS-RRM monomer and accelerated aggregation kinetics, leading to a different fibril state.
Why the study?
FUS-RRM monomers undergo amyloid-like aggregation, but detailed molecular insights into the fibrillation process remain to be deciphered.
Conformational heterogeneity in FUS-RRM is coupled to aggregation kinetics, providing a potential target for structure-based drug discovery in neurodegenerative diseases.
Hypothesis-generating for pH-sensitive FUS targets in neurodegeneration; leaves open any clinical relevance.
The Fused in Sarcoma (FUS) protein, previously implicated in neurodegenerative diseases, contains N- and C-terminal LC-rich regions, a zinc finger motif flanked by two RG-rich regions, and a single RNA-recognition motif (RRM). FUS-RRM monomers undergo amyloid-like aggregation, however, the detailed molecular insights into the fibrillation process are yet to be deciphered. Here, we investigated the conformational heterogeneity of FUS-RRM using NMR relaxation-dispersion experiments. We observed that the monomer (M) exists in a dynamic exchange with an excited state (ES), which gets perturbed by altering the pH. Although the overall fold of the FUS-RRM remains unperturbed at the lower pH, aggregation kinetics increase. The data suggests a coupling of the conformational heterogeneity to aggregation kinetics wherein a perturbation to ES probably acts as a switch that controls the fibrillation process under physiological and stress conditions. These results add to the understanding of the fibrillation process, thereby paving the way for a better understanding of the role of FUS in neurodegenerative diseases. Highlights FUS-RRM displays conformational heterogeneity in its folded monomeric state. A decrease in pH perturbs the conformational heterogeneity of the monomeric state. A lower pH condition accelerates the aggregation rate and also leads to a different fibril state. The conformational heterogeneity provides a wider target search space for potential lead compounds in structure-based drug discovery. Abstract Figure Graphical Abstract
No takes yet. Share an insight, caveat, or question.
Aazmi et al. (2025) studied FUS-RRM fibrillation (Neurodegenerative diseases). Low pH (4.6) vs. Physiological pH (6.4) was evaluated on Conformational exchange dynamics and aggregation kinetics. Lowering pH to 4.6 quenched the conformational exchange of the FUS-RRM monomer and accelerated aggregation kinetics, leading to a different fibril state.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: